Reshape Lifesciences Inc.
13F holders, Q2 2024 (June 30)16holders −2
3new positions
5sold out
$0.19avg. 13F price*
At the end of Q2 2024, 16 institutions reported holding Reshape Lifesciences Inc. in their 13F filings, down 2 from Q1 2024. 3 opened new positions and 5 sold out. The largest holders were Geode Capital Management, LLC ($25K), UBS Group AG ($11K) and Virtu Financial LLC ($11K).
- Company
- Reshape Lifesciences Inc.
- CUSIP
- 76090R200
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $14K |
| Exits | 5 | $16K |
All 13F filers, Q1 2024 → Q2 2024: 250,910 shares bought and 129,427 shares sold, net +121,483 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| Geode Capital Management, LLC | 0.00% | Add +622.5% | 132,566 | $25K |
| UBS Group AG | 0.00% | Add +2887550.0% | 57,753 | $11K |
| Virtu Financial LLC | 0.00% | New | 58,913 | $11K |
| Vanguard Group Inc. | 0.00% | No change | 49,874 | $10K |
| BlackRock Inc. | 0.00% | No change | 34,060 | $7K |
| HRT Financial LP | 0.00% | New | 19,646 | $3K |
| State Street Corp. | 0.00% | No change | 13,015 | $2K |
| XTX Topco Ltd | 0.00% | Add +1.6% | 12,486 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -81.5% | 9,192 | $2K |
| Bank of America Corp. | 0.00% | New | 192 | $37 |
| Cornerstone Planning Group LLC | 0.00% | No change | 135 | $24 |
| Qube Research & Technologies Ltd | 0.00% | Reduce -75.0% | 100 | $19 |
| Group One Trading LLC | 0.00% | No change | 3 | $1 |
| JPMorgan Chase & Co. | 0.00% | No change | 1 | $0 |
| CIBC Private Wealth Group LLC | 0.00% | No change | 1 | $0 |
| Osaic Holdings, Inc. | 0.00% | No change | 5 | $0 |
"% of holder's portfolio" is RESHAPE LIFESCIENCES INC's weight in each manager's 13F, not the share of Reshape Lifesciences Inc. the manager owns.